SHL Telemedicine Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0010855885
CHF
1.10
-6.54 (-85.6%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

281

Shareholding (Jun 2015)

FII

0.01%

Held by 1 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CHF 39 Million ()

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

4.31%

stock-summary
Price to Book

1.30

Revenue and Profits:
Net Sales:
11 Million
(Quarterly Results - Jun 2015)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-85.6%
0%
-85.6%
6 Months
-85.6%
0%
-85.6%
1 Year
-85.6%
0%
-85.6%
2 Years
-85.6%
0%
-85.6%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

SHL Telemedicine Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-6.63%
EBIT Growth (5y)
-22.72%
EBIT to Interest (avg)
-0.07
Debt to EBITDA (avg)
0.58
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
0.75
Tax Ratio
49.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
2.47%
ROE (avg)
2.34%

Valuation key factors

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
0.64
EV to EBIT
9.65
EV to EBITDA
3.69
EV to Capital Employed
0.63
EV to Sales
0.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.54%
ROE (Latest)
4.31%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2015stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'15 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2015 is 19.78% vs 30.00% in Jun 2014",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2015 is -1,300.00% vs 0.00% in Jun 2014",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'15",
        "Jun'14",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.90",
          "val2": "9.10",
          "chgp": "19.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.10",
          "val2": "1.30",
          "chgp": "-15.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.30",
          "chgp": "166.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.20",
          "val2": "0.10",
          "chgp": "-1,300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-39.00%",
          "val2": "6.80%",
          "chgp": "-4.58%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.53% vs -8.88% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -293.55% vs -3,200.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50.00",
          "val2": "51.30",
          "chgp": "-2.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.40",
          "val2": "0.80",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "1.40",
          "chgp": "-14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-16.10",
          "val2": "0.40",
          "chgp": "-4,125.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-24.40",
          "val2": "-6.20",
          "chgp": "-293.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-124.40%",
          "val2": "-119.30%",
          "chgp": "-0.51%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'15 - YoYstock-summary

Jun'15
Jun'14
Change(%)
Net Sales
10.90
9.10
19.78%
Operating Profit (PBDIT) excl Other Income
1.10
1.30
-15.38%
Interest
0.80
0.30
166.67%
Exceptional Items
-0.10
0.00
Consolidate Net Profit
-1.20
0.10
-1,300.00%
Operating Profit Margin (Excl OI)
-39.00%
6.80%
-4.58%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2015 is 19.78% vs 30.00% in Jun 2014

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2015 is -1,300.00% vs 0.00% in Jun 2014

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
50.00
51.30
-2.53%
Operating Profit (PBDIT) excl Other Income
0.40
0.80
-50.00%
Interest
1.20
1.40
-14.29%
Exceptional Items
-16.10
0.40
-4,125.00%
Consolidate Net Profit
-24.40
-6.20
-293.55%
Operating Profit Margin (Excl OI)
-124.40%
-119.30%
-0.51%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -2.53% vs -8.88% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -293.55% vs -3,200.00% in Dec 2023

stock-summaryCompany CV
About SHL Telemedicine Ltd. stock-summary
stock-summary
SHL Telemedicine Ltd.
Pharmaceuticals & Biotechnology
SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.
Company Coordinates stock-summary
Company Details
90 Yigal Alon St. , TEL AVIV-YAFO None : 67891
Registrar Details